Status:
WITHDRAWN
Improving Survivorship Among Minority Cancer Dyads
Lead Sponsor:
Charles Drew University of Medicine and Science
Conditions:
Cancer
Breast Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This proposed intervention centers on improving survivorship outcomes among African American and Latinx cancer survivor and caregiver dyads. As a result, there will be four major outcomes. First, as a...
Eligibility Criteria
Inclusion
- Aim 1 Focus Group for Cancer Survivors and Caregivers:
- Inclusion Criteria
- Individuals ages 18 and older
- identify as African American or Latinx
- identify as a cancer survivor and/or caregiver
- speak and/or understand English
- Exclusion Criteria
- individuals ages 17 years or younger
- does not identify as African American or Latinx
- unable to speak or understand English
- does not identify as a cancer survivor or caregiver
- Aim 1 Focus Group for Oncology Healthcare Providers:
- Inclusion Criteria
- Individuals ages 18 and older
- identify as a healthcare provider
- provide care to cancer patients in current provider role
- speak and/or understand English
- Exclusion Criteria
- individuals ages 17 years or younger
- unable to speak or understand English
- does not provide care to cancer patients
- does not identify as a healthcare provider
- Aim 2:
- Inclusion Criteria
- Individuals ages 18 and older
- registered as a CDU student
- speak and/or understand English
- considered to be underserved, which include a) identifying as an underrepresented minority: Asian, Pacific Islander, African American, Hispanic, and Native American/Alaskan Native and/or b) from a medically underserved population (i.e. faced economic, cultural or linguistic barriers to health care)
- Exclusion Criteria
- individuals ages 17 years or younger
- not registered as a CDU student
- unable to speak or understand English
- not considered to be underserved
- For Aim 3:
- Inclusion Criteria
- cancer survivor with a participating caregiver
- stage III or stage IV cancer diagnosis
- breast, lung, or colorectal cancer diagnosis
- identify as African American or Latinx
- speak and/or understand English
- Exclusion Criteria
- individuals ages 17 years or younger
- does not identify as African American or Latinx
- unable to speak or understand English
- does not identify as a cancer survivor
- cancer survivor does not identify a caregiver
- does not have a breast, lung, or colorectal cancer diagnosis
- not diagnosed with a stage III or stage IV cancer diagnosis
Exclusion
Key Trial Info
Start Date :
July 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04685551
Start Date
July 1 2021
End Date
December 31 2024
Last Update
July 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Charles R. Drew University of Medicine & Science
Los Angeles, California, United States, 90059